title: Kounis Syndrome induced by intravenous administration of piperacillin/tazobactam: a case report.
authors.forename: G F
authors.initials: GF
authors.lastname: Calogiuri
authors.forename: E
authors.initials: E
authors.lastname: Nettis
authors.forename: E
authors.initials: E
authors.lastname: Di Leo
authors.forename: A
authors.initials: A
authors.lastname: Vacca
authors.forename: A
authors.initials: A
authors.lastname: Ferrannini
authors.forename: N G
authors.initials: NG
authors.lastname: Kounis
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects*; D003329:Coronary Vasospasm / Q000139:chemically induced* / Q000175:diagnosis / Q000503:physiopathology; D003937:Diagnosis, Differential; D004562:Electrocardiography / Q000187:drug effects*; D005500:Follow-Up Studies; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D010397:Penicillanic Acid / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives; D010878:Piperacillin / Q000008:administration & dosage / Q000009:adverse effects; D000077725:Piperacillin, Tazobactam Drug Combination; D018410:Pneumonia, Bacterial / Q000188:drug therapy; D013577:Syndrome; D065093:beta-Lactamase Inhibitors
chemical_list: D000900:Anti-Bacterial Agents; D065093:beta-Lactamase Inhibitors; D000077725:Piperacillin, Tazobactam Drug Combination; D010397:Penicillanic Acid; D010878:Piperacillin